Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
Objective assessment of muscle function following botulinum toxin injections in laryngeal muscles is difficult in human subjects. We developed a rat laryngeal model for the study of botulinum toxin injection. A new laryngoscopic technique has made it possible to observe the rat larynx endoscopically and to obtain electromyographic measurements during and after injection of toxin. The electromyographic interference pattern, fibrillation potentials, and vocal fold movement were used for analyzing dose and volume effects of injected toxin. We conclude that the lowest dosage able to produce the maximal duration of functional laryngeal impairment is 0.07 U in a volume of 0.4 microL. This model will enable us to obtain physiologic and histologic parameters that can be used to assess the selection of optimal treatment regimens with botulinum toxin for the treatment of patients with spasmodic dysphonia.
Inagi
K
K
Division of Otolaryngology-Head and Neck Surgery, University of Wisconsin, Madison, USA.
Rodriquez
A A
AA
Ford
C N
CN
Heisey
D M
DM
D000818:Animals; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000379:methods*; D004576:Electromyography; D006801:Humans; D007821:Laryngeal Muscles / Q000187:drug effects*; D007828:Laryngoscopy; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013035:Spasm; D014832:Voice Disorders / Q000188:drug therapy* / Q000503:physiopathology
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A